Pharmacodynamics of Interaction between Propoxazepam and a GABA-Benzodiazepine Receptor-Ionofor Complex
Effects of a propyloxy derivative of 1.4-benzodiazepine, propoxazepam, on GABA-benzodiazepine receptor complexes (GABA RCs) were examined in vitro and in vivo. The parameters of propoxazepam binding to synaptosomes from the rat brain were estimated in vitro. The Ki constant for inhibition of [3H] flumazenil binding by this agent was 3.5 ± 0.3 nM, on average. Considering the value of the GABA shift (1.9), propoxazepam can be considered as GABA-RC full agonist. On the model of picrotoxin-induced seizures in vivo, the propoxazepam average effective dose was estimated as 4.1 ± ± 0.21 mmol/kg. It was found that the parameters of myoclonic components (latent period of the onset of myoclonic seizures and their number), as well as death time of the tested animals, characterize adequately an anticonvulsant action of propoxazepam of picrotoxin-induced seizures in mice. Competitive interaction with picrotoxin is the possible mechanism of these effects at the level of GABAARCs. Significant deviations from a competitive model of monomolecular and cooperative binding of the agent at the receptor level have been found.
Keywordspropoxazepam picrotoxin GABA-benzodiazepine receptor complex affinity anticonvulsant effect
Unable to display preview. Download preview PDF.
- 2.A. V. Cem’yanov, “GABAergic inhibition in the CNS: Types of GABA receptors and mechanisms of tonic GABA-mediated inhibitory action,” Neurophysiology, 34, No. 1, 82–92 (2002).Google Scholar
- 7.V. I. Pavlovsky, T. A. Kabanova, O. I. Khalimova, et al., “Analgesic properties of 1-alkyl-3-acetoxy-1,2-dihydro-3H-1,4-benzodiazepine-2-ons”, Dosyagn. Biol. Med., 1, No. 25, 38-41(2015)Google Scholar
- 10.V. Yu. Urbakh, Statistical Analysis in Biological and Medical Studies, Meditsina, Moscow (1975).Google Scholar
- 11.S. Glantz, Medical/Biological Statistics, Praktika, Moscow (1999).Google Scholar
- 13.Y. C. Cheng and W. H. Prusoff, “Relationship between the inhibition constant (Ki) and the concentration of inhibitor which causes 50% inhibition (IC50) of an enzymatic reaction”, Biochem. Pharmacol., 2, 3099-3108 (1973).Google Scholar
- 16.V. G. Zin’kovskii, N. Ya. Golovenko, and O. V. Zhuk, “Effector analysis of the principles of functioning and cooperativity of the subunits in a GABA-BD-receptorionofor ensemble,” in: Mechanisms of Actions of Anxiolytic, Anticonvulsive, and Soporific Means, Nauk. Dumka, Kyiv (1988), pp. 98-175.Google Scholar
- 17.J. A. Kemp, G. R. Marshall, E. H. Wong, and G. N. Woodruff, “The affinities, potencies and efficacies of some benzodiazepine-receptor agonists, antagonists and inverse-agonists at rat hippocampal GABAA- receptors”, Br. J. Pharmacol., 91, No. 13, 601-608 (1987).CrossRefPubMedPubMedCentralGoogle Scholar
- 18.N. Ya. Golovenko, V. G. Zin’kovskii, O. V. Zhuk, et al., “Optimization of a technique of infusion of reverse agonists of the GABA-receptor complex in the analysis of rapidly reversible effects of tranquilizers and ethanol,” Bull. Eksperim. Biol. Med., 123, No. 5, 551-554 (1997).Google Scholar